Posted in Regulatory Sanofi receives FDA approval for Tzield in paediatric diabetes April 23, 2026 Pharmaceutical Business Review The approval expands the previous indication from those aged eight and above and was granted under a priority review process. RegulatoryMetabolic & GLP-1Read full story